Form 4: Moderna Director Noubar Afeyan Sells Shares Worth Millions

Noubar Afeyan, a director at Moderna, sold shares of the company's common stock on April 3, 2024, under a pre-arranged trading plan.

Summary

• On April 3, 2024, Noubar Afeyan, a director of Moderna, sold shares of the company's common stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on February 27, 2023, and amended on November 7, 2023.
• A total of 15,402 shares were sold at varying prices ranging from $97.47 to $104.15.
• Following the transactions, Afeyan directly owns 2,086,931 shares of Moderna common stock.
• Afeyan also has indirect ownership through Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (9,662,114 shares) and Flagship Pioneering, Inc. (3,924 shares).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily reflect a change in the director's confidence in the company.

Industry Context

Sales by insiders are a common occurrence and are often related to personal financial planning. It's important to consider the overall trend of insider transactions and the context of the company's performance when evaluating the significance of this sale.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment in the short term.
• However, the existence of a pre-arranged trading plan mitigates this impact.

Key Dates